Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET>BRAF+*** > Treatment > USA. G. Vemurafenib ***

---

USA. G. Vemurafenib ***'s subsections
(*) EU Approval Date: 2012. 02.
(*) USA Approval Date: 2011. 08.17.
BRAF Gene V600E/K Mutation(+)
CoDevelopment Partner
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc
Patent>UpDate: 2011. 11.29.
TradeMark
TradeMark Web-Site

USA. G. Vemurafenib ***'s products
This section has no products